Over 130 Buildings and Landmarks in the United States and Canada to Be Illuminated in Support of Stand Up To Cancer's 6th Live Telecast
More than 130 iconic buildings and landmarks across the United States and Canada will be illuminated in a show of support for the 6th biennial Stand Up To Cancer (SU2C) “roadblock” telecast airing in both countries on Friday, September 7 (8:00–9:00 PM ET/PT, 7:00–8:00 PM CT). All sites will light up in different combinations of SU2C's signature colors: orange, red, yellow, gray, and white.
The New York Stock Exchange; the Wrigley Building in Chicago; Niagara Falls; the Peace Bridge connecting Buffalo and Fort Erie, Ontario; the Helmsley Building in New York City; the Capital Wheel outside Washington, DC; One Liberty Place, Cira Tower, and FMC Tower in Philadelphia; and others are among the major U.S. buildings and landmarks lighting up in support of SU2C, which is commemorating 10 years of raising awareness and funds for groundbreaking cancer research that is saving lives.
In Canada, the 3D TORONTO sign; Calgary Tower and Reconciliation Bridge in Calgary; High Level Bridge in Edmonton; Sails of Light and BC Place Stadium in Vancouver; and the London Convention Center in London, Ontario, will join Niagara Falls and the Peace Bridge in lighting up for SU2C.
A full list of the buildings and landmarks to be illuminated in honor of SU2C can be found here.
“We are honored to have our 10 years of impact recognized by so many iconic landmarks across the U.S. and Canada,” said Sung Poblete, President and Chief Executive Officer of Stand Up To Cancer. “Illuminating buildings in SU2C's signature colors across both countries brilliantly symbolizes our emphasis on collaboration and teamwork in SU2C's life-saving research.”
About the Telecast
Actor Bradley Cooper will return as Co-Executive Producer of the telecast. Other stars joining the program include Jennifer Garner, Ed Helms, Ken Jeong, Matthew McConaughey, Trevor Noah, Dak Prescott, Keith Urban, and Reese Witherspoon.
The telecast will broadcast live from The Barker Hangar in Santa Monica, California. As in years past, ABC, CBS, FOX, and NBC, along with the American Heroes Channel, AT&T Audience Network, Bloomberg TV, Bravo, Destination America, Discovery Family, Discovery Life, E!, Epix, Escape, ESPNews, FM, Freeform, FS2, FXM, FYI, Galavision, Great American Country, HBO, HBO Latino, ION Television, Jewish Life TV, Laff, Logo, MTV2, Nat Geo Wild, Reelz, Showtime, Smithsonian Channel, Starz, Starz Encore, Starz Encore Español, TNT, Univision Puerto Rico, and WGN America are donating 1 hour of simultaneous commercial-free primetime for the telecast, with additional networks to be announced.
Following the live broadcast, the telecast will be available to stream via ComedyCentral.com and the Comedy Central app, as well as its video on-demand partners. Aspire TV will air the Stand Up To Cancer telecast on Saturday, September 8 at 8:00 AM-9:00 AM ET/PT / 10:00 AM CT. The entire telecast will also stream live on SU2C's Facebook page and PeopleTV, as well as stream live and on-demand on Hulu and SU2C's YouTube channel.
For the third time, Stand Up To Cancer Canada will simultaneously broadcast a Canada-inclusive telecast across four major English-language Canadian broadcasters: CBC, Citytv, CTV, and Global, as well as the Canadian services AMI, A.Side, BBC Earth, CHCH, CHEK, Cottage Life, Fight Network, Game TV, HIFI, Hollywood Suite, Love Nature, Makeful, NTV, OUTtv, Smithsonian Channel Canada, T+E, and YES TV. In addition, the show will stream live on the CBC TV App, cbc.ca/watch, CBS All Access, CTV GO and CTV.ca, Global GO, and GlobalTV.com and will be available on-demand on TELUS Optik TV in Canada.
10-Year Anniversary
The 2018 show is especially significant for SU2C, as it commemorates 10 years of raising awareness and funds for innovative cancer research. To date, more than $480 million has been pledged in support of SU2C's innovative cancer research programs. The organization has brought together more than 1,500 scientists from over 180 leading institutions with an emphasis on collaborative, multidisciplinary teams that deliver new therapies and treatments to cancer patients. Scientists work together on Stand Up To Cancer's 24 signature “Dream Teams,” among a total of 79 team science grants and awards. SU2C-funded researchers have planned, launched, or completed more than 180 clinical trials involving over 12,000 patients.
SU2C research has contributed to U.S. Food and Drug Administration approval of five new cancer therapies, including treatments for breast, ovarian, and pancreatic cancers, and difficult-to-treat leukemias. Additional trial results have been submitted or are nearing completion for breast, colon, ovarian, and prostate cancers, as well as for metastatic melanoma. Stand Up To Cancer has provided substantial funding for the study of immunotherapy in the fight against cancer and has advanced the development of technologies using blood tests to identify cancers early, imaging to understand tumor progression, and precision medicine via new laboratory tools.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
